Form 4: Codexis Director Christos Richards Granted Over 40,000 Restricted Stock Units
Insider Transaction Report
Codexis, Inc. Director Christos Richards has been granted 40,983 shares of common stock in the form of restricted stock units, aligning his interests with shareholders.
Summary
- Christos Richards, a Director of Codexis, Inc. (CDXS), acquired 40,983 shares of common stock on June 10, 2025.
- The acquisition was a grant of Restricted Stock Units (RSUs) at a price of $0 per share.
- Following this transaction, Mr. Richards beneficially owns a total of 85,133 shares of common stock directly.
- The restricted stock units are set to vest as to all shares on the earlier of the first anniversary of the grant date (June 10, 2025) or the next annual stockholder meeting, contingent on Mr. Richards' continued service to the company.
Sentiment
Score: 7
Explanation: The grant of restricted stock units to a director is generally a positive signal, indicating alignment of interests between the board and shareholders, and confidence in the company's future. It is a standard compensation practice.
Positives
- The grant of restricted stock units to a director aligns management's interests with those of the shareholders, as the value of the compensation is tied to the company's stock performance.
- An increase in a director's beneficial ownership can be viewed as a positive signal of their confidence in the company's future prospects.
Future Outlook
The restricted stock units granted to Director Christos Richards are expected to vest fully on the earlier of June 10, 2026, or the date of the next annual stockholder meeting, provided his continued service to the company.
Industry Context
The grant of restricted stock units is a common form of equity compensation for directors in the biotechnology and life sciences industry, aiming to incentivize long-term commitment and align their financial interests with company performance.
Stakeholder Impact
- Shareholders: The RSU grant aligns the director's financial interests with shareholder value, as the value of the compensation is directly tied to the company's stock performance.
- Employees: While not directly impacting general employees, such compensation practices for leadership can set a precedent for performance-based incentives within the company.
Next Steps
- The vesting of the 40,983 restricted stock units will occur on the earlier of June 10, 2026, or the next annual stockholder meeting, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 06/10/2025 | Date of transaction where Christos Richards acquired 40,983 Restricted Stock Units. |
| 06/12/2025 | Date the Form 4 filing was signed by Georgia Erbez, as Attorney-in-Fact for Christos Richards. |
| 06/10/2026 | Earliest potential vesting date for the restricted stock units (first anniversary of grant date), subject to earlier vesting if the next annual stockholder meeting occurs before this date. |
Keywords
SEC Form 4, Codexis, CDXS, Restricted Stock Units, RSU grant, insider transaction, director compensation, beneficial ownership, equity compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.